ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months

Saved in:
Bibliographic Details
Published in:Molecular genetics and metabolism 2015-02, Vol.114 (2), p.S81-S82
Main Authors: Mistry, Pramod, Amato, Dominick J., Dasouki, Majed, Packman, Seymour, Pastores, Gregory M., Assouline, Sarit, Balwani, Manisha, Ortega, Andres, Shankar, Suma, Solano, Maria Helena, Ross, Leorah H., Angell, Jennifer, Peterschmitt, M. Judith
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1096-7192
DOI:10.1016/j.ymgme.2014.12.179